Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

RoosterBio Blog

Analytics: Time to Scratch the “30-Year Itch” from MSCs’ Questions

June 30, 2022 MSCs & Characterization

“One morning I woke up… A new day, a new way… And new eyes to see the dawn.” [1] Ah, the joy of discovery, like Promethean fire wrested from the ... More

Highlights from ISEV 2022: In-Person Inspires In-Depth EV/Exosome Discussions & Analysis

June 16, 2022 Conference Highlights, Exosomes / Extracellular Vesicles

Introduction After two years of virtual-only meetings, ISEV 2022 kicked off in-person in the beautiful city of Lyon, France from May 25-29 with an estimated over 1500 attendees, including five ... More

Life at the Roost: An Interview with Elie Zakhem, Manager of Process Development

June 01, 2022 Corporate

Listen to this Blog:  Your browser does not support audio. Jon Carson: Another edition of Life at the Roost is now upon us! And so, I’m really thrilled to ... More

Sidebar Navigation

  • BioEconomy
  • Biomanufacturing
  • Bioprinting & Biofabrication
  • Bioprocessing
  • Cell Therapy
  • Conference Highlights
  • Corporate
  • COVID-19
  • Exosomes / Extracellular Vesicles
  • Genetic Engineering
  • MSCs & Characterization
  • Quality & Regulatory
  • Tissue Engineering
#1 Most Popular Blogs 3D Culture Adipose MSCs Adult Stem Cells Advanced Therapies Analytics BioEconomy Biomanufacturing Biomaterials Bioprinting / Biofabrication Bioprocess Bioreactors Bone Marrow MSCs Cell Therapy Clinical Trials COVID-19 Democratizing Technology Exosomes / Extracellular Vesicles Fetal Bovine Serum Genetic Engineering GMP Manufacturing Mesenchymal Stem / Stromal Cells Regenerative Medicine Regulatory RoosterBio Standardization Tissue Engineering Umbilical Cord MSCs

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email